MROH8
geneOn this page
Also known as dJ621N11.4dJ621N11.3
Summary
MROH8 (maestro heat like repeat family member 8, HGNC:16125) is a protein-coding gene on chromosome 20q11.23, encoding Protein MROH8 (Q9H579).
The protein encoded by this gene belongs to the maestro heat-like repeat family. The exact function of this gene is not known, however, in a genome-wide association study using hippocampal atrophy as a quantitative trait, this gene has been associated with Alzheimer’s disease (PMID:19668339). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 140699 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_152503
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16125 |
| Approved symbol | MROH8 |
| Name | maestro heat like repeat family member 8 |
| Location | 20q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ621N11.4, dJ621N11.3 |
| Ensembl gene | ENSG00000101353 |
| Ensembl biotype | protein_coding |
| Entrez | 140699 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000343811, ENST00000400440, ENST00000421643, ENST00000422138, ENST00000434295, ENST00000466091
RefSeq mRNA: 3 — MANE Select: NM_152503
NM_152503, NM_213631, NM_213632
Canonical transcript exons
ENST00000343811 — 25 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001642508 | 37141162 | 37141314 |
| ENSE00001650973 | 37158892 | 37159036 |
| ENSE00001722665 | 37155063 | 37155167 |
| ENSE00003636869 | 37160097 | 37160176 |
| ENSE00003638675 | 37171912 | 37172057 |
| ENSE00003661583 | 37173995 | 37174116 |
| ENSE00003670937 | 37168121 | 37168243 |
| ENSE00003972712 | 37143717 | 37143841 |
| ENSE00003972713 | 37112324 | 37112446 |
| ENSE00003972714 | 37119698 | 37119838 |
| ENSE00003972715 | 37102664 | 37102835 |
| ENSE00003972716 | 37110256 | 37110355 |
| ENSE00003972717 | 37113990 | 37114145 |
| ENSE00003972718 | 37115173 | 37115337 |
| ENSE00003972719 | 37179389 | 37179548 |
| ENSE00003972720 | 37129032 | 37129167 |
| ENSE00003972721 | 37179223 | 37179387 |
| ENSE00003972722 | 37120504 | 37120618 |
| ENSE00003972725 | 37108599 | 37108664 |
| ENSE00003972726 | 37137810 | 37137970 |
| ENSE00003972727 | 37147774 | 37147909 |
| ENSE00003972729 | 37157860 | 37157955 |
| ENSE00003972731 | 37120899 | 37121036 |
| ENSE00003972733 | 37123609 | 37123799 |
| ENSE00003972734 | 37101226 | 37101418 |
Expression profiles
Bgee: expression breadth ubiquitous, 174 present calls, max score 89.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.4468 / max 75.2944, expressed in 1096 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 187172 | 2.2276 | 1046 |
| 187173 | 0.2192 | 104 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 89.35 | gold quality |
| left testis | UBERON:0004533 | 89.28 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.32 | gold quality |
| testis | UBERON:0000473 | 87.60 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.64 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 82.50 | gold quality |
| buccal mucosa cell | CL:0002336 | 80.12 | silver quality |
| sperm | CL:0000019 | 79.35 | gold quality |
| bone marrow cell | CL:0002092 | 79.12 | gold quality |
| muscle of leg | UBERON:0001383 | 77.78 | gold quality |
| gastrocnemius | UBERON:0001388 | 77.59 | gold quality |
| apex of heart | UBERON:0002098 | 76.49 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.14 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.10 | gold quality |
| adenohypophysis | UBERON:0002196 | 76.01 | gold quality |
| ventricular zone | UBERON:0003053 | 75.68 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 75.56 | gold quality |
| pituitary gland | UBERON:0000007 | 75.42 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 75.41 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.20 | gold quality |
| right frontal lobe | UBERON:0002810 | 75.00 | gold quality |
| right lobe of liver | UBERON:0001114 | 74.87 | gold quality |
| cerebellum | UBERON:0002037 | 74.64 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.60 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 74.39 | gold quality |
| right atrium auricular region | UBERON:0006631 | 74.00 | gold quality |
| hypothalamus | UBERON:0001898 | 73.44 | gold quality |
| cardiac atrium | UBERON:0002081 | 73.44 | gold quality |
| nucleus accumbens | UBERON:0001882 | 73.28 | gold quality |
| sural nerve | UBERON:0015488 | 72.79 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 8.01 |
| E-ANND-3 | no | 5.88 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting MROH8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-451B | 99.55 | 68.28 | 1380 |
| HSA-MIR-543 | 99.52 | 69.03 | 2595 |
| HSA-MIR-513C-5P | 99.50 | 68.42 | 1730 |
| HSA-MIR-514B-5P | 99.50 | 68.19 | 1766 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
| HSA-MIR-593-3P | 99.22 | 67.28 | 1327 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-4463 | 98.56 | 66.05 | 1071 |
| HSA-MIR-10397-5P | 97.31 | 69.06 | 710 |
| HSA-MIR-216B-5P | 97.16 | 66.76 | 1126 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mroh8 | ENSMUSG00000074627 |
| rattus_norvegicus | Mroh8 | ENSRNOG00000007341 |
Paralogs (8): MROH9 (ENSG00000117501), MRO (ENSG00000134042), MROH2B (ENSG00000171495), MROH1 (ENSG00000179832), MROH7 (ENSG00000184313), MROH2A (ENSG00000185038), MROH6 (ENSG00000204839), MROH5 (ENSG00000226807)
Protein
Protein identifiers
Protein MROH8 — Q9H579 (reviewed: Q9H579)
Alternative names: Maestro heat-like repeat-containing protein family member 8
All UniProt accessions (4): A0A8V8TLF2, A0A8V8TLY2, A0A8V8TN72, Q5JYQ9
UniProt curated annotations — full annotation on UniProt →
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H579-1 | 1 | yes |
| Q9H579-2 | 2 |
RefSeq proteins (3): NP_689716, NP_998796, NP_998797 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR045206 | Maestro_heat-like_prot | Family |
| IPR048465 | Maestro-like_HEAT | Domain |
| IPR055408 | HEAT_MROH2B-like | Domain |
Pfam: PF21047, PF23210
UniProt features (4 total): splice variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H579-F1 | 74.20 | 0.28 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 45 (showing top):
chr20q11, DODD_NASOPHARYNGEAL_CARCINOMA_DN, ALKBH3_TARGET_GENES, BARX1_TARGET_GENES, ELF2_TARGET_GENES, FEV_TARGET_GENES, FOXD2_TARGET_GENES, FOXN3_TARGET_GENES, GUCY1B1_TARGET_GENES, PRKDC_TARGET_GENES, CASP8AP2_TARGET_GENES, ZFHX3_TARGET_GENES, ZFP91_TARGET_GENES, ZNF30_TARGET_GENES, ZNF391_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
318 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MROH8 | OR9G1 | Q8NH87 | 626 |
| MROH8 | NUTM2G | Q5VZR2 | 507 |
| MROH8 | KRTAP9-1 | A8MXZ3 | 505 |
| MROH8 | BBOF1 | Q8ND07 | 499 |
| MROH8 | UBE3B | Q7Z3V4 | 494 |
| MROH8 | NFS1 | Q9Y697 | 434 |
| MROH8 | MCRIP1 | C9JLW8 | 419 |
| MROH8 | SHANK3 | Q9BYB0 | 418 |
| MROH8 | POLR3F | Q9H1D9 | 411 |
| MROH8 | MTCL2 | O94964 | 390 |
| MROH8 | CLEC12B | Q2HXU8 | 384 |
| MROH8 | PLA2G1B | P04054 | 372 |
| MROH8 | METTL21C | Q5VZV1 | 364 |
| MROH8 | ARMC10 | Q8N2F6 | 360 |
| MROH8 | AK3 | Q9UIJ7 | 352 |
IntAct
0 interactions, top by confidence:
BioGRID (5): MROH8 (Affinity Capture-MS), MROH8 (Affinity Capture-MS), MROH8 (Affinity Capture-MS), MROH8 (Affinity Capture-RNA), APP (Reconstituted Complex)
ESM2 similar proteins: A0A0M3U1B0, A1A5Q6, A2AFS9, A2AVR2, A2CI98, A2CJ06, A2RTY3, A2RUW0, O70167, O70173, P0C2Y1, P15304, P59729, Q08EC4, Q3SYK4, Q3TYG6, Q3U1D0, Q4R744, Q4R9E9, Q5R4B2, Q5T4T6, Q5TGP6, Q5VWK0, Q68CQ1, Q6AYJ3, Q6IFT4, Q6IRU7, Q6REY9, Q6ZUA9, Q7Z572, Q80VH0, Q86WZ0, Q86XG9, Q8C0X8, Q8CCC3, Q8ND61, Q8NDZ2, Q8TB24, Q96M43, Q96QP1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 7 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
91 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:37179365:GCCGG:G | donor_gain | 0.9900 |
| 20:37179312:G:GT | donor_gain | 0.9800 |
| 20:37179355:G:GT | donor_gain | 0.9800 |
| 20:37179356:A:T | donor_gain | 0.9800 |
| 20:37179366:CCGGG:C | donor_loss | 0.9800 |
| 20:37179367:CGGGT:C | donor_loss | 0.9800 |
| 20:37179368:GG:G | donor_gain | 0.9800 |
| 20:37179369:GG:G | donor_gain | 0.9800 |
| 20:37179370:G:GG | donor_gain | 0.9800 |
| 20:37179370:G:T | donor_loss | 0.9800 |
| 20:37179371:T:C | donor_loss | 0.9800 |
| 20:37179372:G:GG | donor_loss | 0.9600 |
| 20:37179375:GAGT:G | donor_gain | 0.9600 |
| 20:37179378:T:G | donor_gain | 0.9600 |
| 20:37179352:G:GT | donor_gain | 0.9500 |
| 20:37179090:TTCC:T | donor_gain | 0.9200 |
| 20:37179544:G:GT | donor_gain | 0.9100 |
| 20:37179312:G:T | donor_gain | 0.8700 |
| 20:37179475:GGGCA:G | donor_gain | 0.8500 |
| 20:37179519:TCCG:T | donor_gain | 0.8400 |
| 20:37179542:TGG:T | donor_gain | 0.8400 |
| 20:37179543:GGG:G | donor_gain | 0.8400 |
| 20:37179394:G:T | donor_gain | 0.8200 |
| 20:37179526:G:GT | donor_gain | 0.8200 |
| 20:37179394:G:GT | donor_gain | 0.8000 |
| 20:37179415:G:T | donor_gain | 0.7900 |
| 20:37179415:G:GT | donor_gain | 0.7700 |
| 20:37179087:C:A | donor_gain | 0.7600 |
| 20:37179449:C:T | donor_gain | 0.7600 |
| 20:37179422:C:G | donor_gain | 0.7500 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000076422 (20:37176368 C>T), RS1000089342 (20:37148464 G>A,T), RS1000089973 (20:37104376 CAA>C), RS1000091599 (20:37140621 T>C), RS1000168352 (20:37164113 TCTTTC>T), RS1000226770 (20:37124989 A>C), RS1000235443 (20:37179254 C>A,T), RS1000253161 (20:37148148 G>A), RS1000262990 (20:37172842 T>C), RS1000300326 (20:37166121 T>C), RS1000347215 (20:37172979 C>G), RS1000406792 (20:37161084 GAA>G), RS1000419494 (20:37172746 C>A), RS1000461781 (20:37117918 A>G), RS1000474134 (20:37180838 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (1): congenital disorder of glycosylation (MONDO:0015286)
Orphanet (1): Congenital disorder of glycosylation (Orphanet:137)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000461_9 | Hippocampal atrophy | 2.000000e-06 |
| GCST009856_24 | Leukocyte telomere length | 1.000000e-07 |
| GCST90002404_577 | Red cell distribution width | 3.000000e-32 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005039 | hippocampal atrophy |
| EFO:0009188 | Red cell distribution width |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D018981 | Congenital Disorders of Glycosylation | C16.320.565.202.125; C18.452.648.202.125 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases expression | 3 |
| Benzo(a)pyrene | decreases expression | 2 |
| methyleugenol | decreases expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| butyraldehyde | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Quercetin | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
9 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT07572825 | PHASE1 | NOT_YET_RECRUITING | Assessing the Safety and Tolerability of NMN in DHDDS-CDG |
| NCT02089789 | Not specified | RECRUITING | Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation |
| NCT02503267 | Not specified | UNKNOWN | Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects |
| NCT02955264 | Not specified | COMPLETED | Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation |
| NCT03250728 | Not specified | COMPLETED | Role of the Endothelium in Stroke-like Episode Among CDG Patients |
| NCT03560570 | Not specified | COMPLETED | Study of Hemostasis in Patients With Congenital Disorder of Glycosylation |
| NCT04198987 | Not specified | COMPLETED | Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation |
| NCT04199000 | Not specified | RECRUITING | Clinical and Basic Investigations Into Congenital Disorders of Glycosylation |
| NCT04201067 | Not specified | COMPLETED | Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital disorder of glycosylation